ActualitésAssisté par IA

Suven Pharma Welcomes Declan Ryan As New CCO To Drive Growth

Suven Pharma appoints Declan Ryan as CCO, bringing 25 years of experience in pharma and biotech.

Par Simantini Singh Deo

Rédacteur principal de contenu

15 oct. 2024Updated Jun 26, 2025 · 2 min de lecture

Partager Ajouter comme source préférée

Suven Pharma Welcomes Declan Ryan As New CCO To Drive Growth — https://www.indianpharmapost.com/people/suven-pharma-appoints-declan-ryan-as-cco-16322

Journalisme assisté par IA

Reviewed by Simantini Singh Deo, Rédacteur principal de contenu

Suven Pharma is pleased to announce the appointment of Declan Ryan as its Chief Commercial Officer. With an impressive 25-year track record in the pharmaceutical and biotech industries, Declan has demonstrated exceptional skills in driving business development and growth.

He holds a Ph.D. from the University of Lausanne and completed postdoctoral research at Yale and the University of Pittsburgh. Throughout his career, he has held pivotal roles at leading companies, including WuXi, Shanghai ChemPartner, AMRI, Johnson & Johnson, and Novartis.

SujetsNews

Written by

Simantini Singh Deo

Rédacteur principal de contenu

Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.